BERKELEY, Calif.--(BUSINESS WIRE)--Acrigen Biosciences, Inc. (“Acrigen”), an early-stage biotechnology company developing precision gene editing technology and genetic medicines, today announced its ...
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today ...